| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 4 | US FAERS | |
| 2 | Exenatide | FAERS: 3 | US FAERS | |
| 3 | Clozapine | FAERS: 1 | US FAERS | |
| 4 | Deferasirox | FAERS: 1 | US FAERS | |
| 5 | Linagliptin | FAERS: 1 | US FAERS | |
| 6 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 7 | Sorafenib | FAERS: 1 | US FAERS | |
| 8 | Terbinafine | FAERS: 1 | US FAERS | |
| 9 | Varenicline | FAERS: 1 | US FAERS | |
| 10 | dofetilide | FAERS: 1 | US FAERS | |
| 11 | rucaparib | FAERS: 1 | US FAERS | |
| 12 | Cromolyn Sodium | OFFSIDES | ||
| 13 | Cromolyn Sodium | OFFSIDES | ||
| 14 | Lamivudine | SIDER | ||
| 15 | Procaterol | OFFSIDES | ||
| 16 | Salmeterol Xinafoate | OFFSIDES | ||
| 17 | Sodium picosulfate | OFFSIDES | ||
| 18 | pyranoprofen | OFFSIDES | ||
| 19 | regorafenib | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.